Skip to main content

Cumberland Pharmaceuticals Inc

CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001087294

No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cumberland Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cumberland Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cumberland Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
Kazimi A JChairman and CEO5,695,310Mar 20, 20266
Brown Martin S JRDirector10,300Mar 20, 20261
Jones JamesDirector46,863Mar 20, 20265
Herman James LVP and Chief Compliance Office38,255Mar 20, 20261
Galante Joseph CDirector63,656Mar 20, 20261
Young CarolineDirector35,109Mar 20, 20265
Krogulski KennethDirector302,338Mar 20, 20265
Hamm John M.VP Chief Financial Officer20,073Mar 20, 20261
Bitterman Chris T.Vice Pres Sales & Marketing4,683Mar 20, 20261
Anthony Todd M.Vice Pres Organizational Dev16,328Mar 20, 20261
Jacobs Joey ADirector98,415Mar 21, 20230
Pavliv LeoSVP and Chief Development Off.129,618Jul 1, 20220
Cearnal Martin ESr VP/Chief Commercial Officer163,473Apr 29, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 11, 2025 (view filing)Jun 2-3039 daysLateYoung CarolineDirectorPPurchase+84$4.80+$403.6+0.3%32.7K after20 lots10b5-1
Aug 11, 2025 (view filing)Jul 1-3141 daysLateKrogulski KennethDirectorPPurchase+1.71K$3.43+$5.87K+0.6%288.3K after22 lots
Aug 11, 2025 (view filing)Jul 1-3141 daysLateKazimi A JChairman and CEOPPurchase+340$3.43+$1.17K0.0%5.70M after22 lots
Aug 11, 2025 (view filing)Jul 1-3141 daysLateJones JamesDirectorPPurchase+340$3.43+$1.17K+0.8%43.7K after22 lots
Aug 11, 2025 (view filing)Jul 1-3141 daysLateYoung CarolineDirectorPPurchase+168$3.44+$577.9+0.5%32.8K after22 lots
Sep 12, 2025 (view filing)Aug 1-2942 daysLateKrogulski KennethDirectorPPurchase+1.37K$3.29+$4.52K+0.5%289.7K after21 lots10b5-1
Sep 12, 2025 (view filing)Aug 1-2942 daysLateKazimi A JChairman and CEOPPurchase+262$3.29+$861.570.0%5.70M after21 lots10b5-1
Sep 12, 2025 (view filing)Aug 1-2942 daysLateJones JamesDirectorPPurchase+262$3.29+$861.57+0.6%43.9K after21 lots10b5-1
Sep 12, 2025 (view filing)Aug 1-2942 daysLateYoung CarolineDirectorPPurchase+121$3.29+$397.89+0.4%32.9K after21 lots10b5-1